Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03046524 · ClinicalTrials.gov registry record
Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior
A clinical trial of Parathyroid Carcinoma and Parathyroid Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT03046524: Completed study of Parathyroid Carcinoma and Parathyroid Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT03046524 is a study of Parathyroid Carcinoma and Parathyroid Neoplasm that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03046524, a study of Parathyroid Carcinoma and Parathyroid Neoplasm, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Objectives: 1. Identify the clinical characteristics of parathyroid (PTH) cancer and PTH atypical neoplasms 2. Investigate if PTH carcinoma and atypical neoplasm present a biological behaviour and have a different impact on the health of the patients
Conditions Studied
Interventions
- OTHER Chart Review
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-10-06 |
| Est. Completion | 2017-10-16 |
What the finished NCT03046524 record still lists
NCT03046524 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Parathyroid Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Chart Review is the first listed.
NCT03046524 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03046524 about?
NCT03046524 is a clinical study titled "Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior". Objectives: 1. Identify the clinical characteristics of parathyroid (PTH) cancer and PTH atypical neoplasms 2. Investigate if PTH carcinoma and atypical neoplasm present a biological behaviour and have a different impact on the health of the patients
What is the current status of trial NCT03046524?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-10-06. Estimated completion is 2017-10-16.
What conditions does trial NCT03046524 study?
This clinical trial studies the following conditions: Parathyroid Carcinoma, Parathyroid Neoplasm.
What interventions are being tested in trial NCT03046524?
The interventions under investigation include: Chart Review (OTHER).
Who is sponsoring clinical trial NCT03046524?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03046524 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI